Abstracts Archive - Page 491 of 1683 - ATC Abstracts

2020 American Transplant Congress
Serum Osteopontin Level is Negatively Associated with Vascular Reactivity Index by Digital Thermal Monitoring in Kidney Transplant Patients
B. Hsu¹, Y. Lai¹, M. Lee²
¹Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, ²Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
*Purpose: Osteopontin (OPN) is a potent inhibitor of mineralization and is a potent inducible inhibitor of vascular calcification. Studies in patients noted elevated levels of…
2020 American Transplant Congress
Long-Term Effect of Kidney Transplantation on Peripheral Arterial Disease
C. Choi¹, M. Ahn¹, S. Kim¹, A. Han², H. Ohe³, S. Min², S. Ahn², S. Min², J. Ha²
¹Transplantation and Vascular Surgery, Chungnam National University Hospital, Daejeon, Korea, Republic of, ²Transplantation and Vascular Surgery, Seoul National University Hospital, Seoul, Korea, Republic of, ³Transplantation and Vascular Surgery, Inje University College of Medicine, Seoul, Korea, Republic of
*Purpose: Peripheral arterial disease (PAD) that needs treatment is common and major complication in patients with chronic kidney disease (CKD). Most surgeons have been using…
2020 American Transplant Congress
Persistent Tertiary Hyperparathyroidism in the First Year after Kidney Transplantation is Associated with Calcium Phosphate Deposition in the Kidney Allograft
R. S. Avasare¹, N. K. Andeen², M. Stack¹, E. N. Dewey³, S. Rehman¹, M. Shindo⁴, J. Y. Lim³
¹Nephrology & Hypertension, OHSU, Portland, OR, ²Pathology, OHSU, Portland, OR, ³Surgery, OHSU, Portland, OR, ⁴Otolaryngology, OHSU, Portland, OR
*Purpose: To investigate risk factors for calcium phosphate deposition in the kidney allograft.*Methods: This is a single-institution, retrospective analysis of adult patients who underwent kidney…
2020 American Transplant Congress
Safely Increasing the Number of Renal Transplants Performed in a Small Center Through the Use of Acute Kidney Injury Donors
S. Batie¹, K. Eid², K. Gabrys³, F. Barrantes³, B. Trujillo², H. Kerr²
¹Presbyterian Healthcare Services, University of New Mexico Health Sciences Center, Albuquerque, NM, ²Presbyterian Healthcare Services, Albuquerque, NM, ³Renal Medicine Associates, Presbyterian Healthcare Services, Albuquerque, NM
*Purpose: New Mexico is medically underserved state with a significant end-stage renal disease population. This study aims to further demonstrate the safety of utilizing AKI…
2020 American Transplant Congress
Renal Transplant Induction Therapy Safety Outcomes Comparison
R. M. Hofmann¹, J. Combs², K. J. Schmidt³, T. Dyckman⁴
¹Nephrology, Renal Associates of West Michigan, Grand Rapids, MI, ²Pharmacy/Transplant, Mercy Health St. Mary's, Grand Rapids, MI, ³Pharmacy, Ferris State University College of Pharmacy, Big Rapids, MI, ⁴Pharmacy, Mercy Health St. Mary's, Grand Rapids, MI
*Purpose: Induction immunosuppression with alemtuzumab and rabbit anti-thymocyte globulin (r-ATG) reduces acute rejection following kidney transplantation. Efficacy is thought to be similar between the agents…
2020 American Transplant Congress
The Role of Antigen Presentation in B Regulatory Cell Function
A. Cuenca¹, N. Feeney², K. Deng², Q. Fu², G. Huai², C. Rickert², K. Lee², J. Markmann²
¹Boston Children's Hospital, Boston, MA, ²Massachusetts General Hospital, Boston, MA
*Purpose: B regulatory cells (B regs) represent a subset of B cells with non-canonical regulatory function. The majority of effort has been focused on the…
2020 American Transplant Congress
Calcium Oxalate Deposition in Kidney Allografts: Clinical Chracteristics and Outcome
S. Sritharan¹, J. Kamal², S. A. Husain¹, I. Batal¹, J. Chang¹
¹Columbia University Irving Medical Center, New York, NY, ²University of Virginia, Charlottesville, VA
*Purpose: To better understand its clinical significance and prognostic value, we investigated the clinical characteristics and outcomes of patients with calcium oxalate deposition in kidney…
2020 American Transplant Congress
Risk Factors for Losing Varicella Immunity after Pediatric Kidney Transplantation
H. Pizzo¹, J. Mirocha², J. Garrison¹, P. R. Soni³, S. Nadipuram³, D. Puliyanda¹
¹Pediatric Nephrology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Biostatistics Core, Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, ³Pediatric Infectious Disease, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Vaccination against varicella zoster (VZV) pre-kidney transplant (kid tx) can help prevent severe disseminated VZV disease in immunosuppressed patients (pts) post-tx. Despite confirmation of…
2020 American Transplant Congress
Impact of Immunosuppression Protocol on the Incidence of EBV Viremia and PTLD in Pediatric Kidney Transplant Recipients: A Single Center Experience
K. Bowers¹, V. M. Panzarino¹, A. Campos¹, J. Buggs², V. D. Bowers²
¹Pediatrics, USF, Tampa, FL, ²Transplant Surgery, TGH, Tampa, FL
*Purpose: The purpose of this study was to evaluate the efficacy of an immunosuppression protocol change, which included avoidance of anti-thymocyte globulin for induction and…
2020 American Transplant Congress
Muscle Strength and Physical Functioning in Pediatric Kidney Transplant Recipients
K. Sgambat, K. Amatya, A. Moudgil
Nephrology, Children's National, Washington, DC
*Purpose: Children with end stage renal disease on dialysis are known to be at high risk for protein energy wasting and low muscle mass, however…